Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
David M. Williams, Asif Nawaz, Marc Evans
Diabetes Therapy (2019) Vol. 11, Iss. 2, pp. 369-386
Open Access | Times Cited: 59

Showing 26-50 of 59 citing articles:

Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR
Adam Arshad, Nadia Sarween, Adnan Sharif
Kidney International Reports (2021) Vol. 6, Iss. 9, pp. 2415-2424
Open Access | Times Cited: 13
Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study
Takamasa Iwakura, Hirotaka Fukasawa, Atsushi Kitamura, et al.
PLoS ONE (2020) Vol. 15, Iss. 2, pp. e0229377-e0229377
Open Access | Times Cited: 14
SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
Rohit Singhal, Lisa Aimee Hechanova
Current Cardiology Reports (2022) Vol. 24, Iss. 3, pp. 183-189
Closed Access | Times Cited: 8
Treatment paradigm shifting implications of recent cardiovascular outcome trials: Core insights on the brink of the 2020ies
Eberhard Standl, Oliver Schnell
Diabetes Research and Clinical Practice (2020) Vol. 161, pp. 108054-108054
Closed Access | Times Cited: 11
Diabetes and Novel Coronavirus Infection: Implications for Treatment
David M. Williams, Asif Nawaz, Marc Evans
Diabetes Therapy (2020) Vol. 11, Iss. 9, pp. 1915-1924
Open Access | Times Cited: 11
Recent therapeutic targets in diabetic nephropathy
Marwa Mohsen, Ahmed A. Elberry, Alaa Mohamed Rabea, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 11
Open Access | Times Cited: 9
Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs
Hyo Jin Kim, Sang Soo Kim, Sang Heon Song
The Korean Journal of Internal Medicine (2022) Vol. 37, Iss. 3, pp. 502-519
Open Access | Times Cited: 6
Glucose‐lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology
Tianpei Hong, Qing Su, M Kellis, et al.
Diabetes/Metabolism Research and Reviews (2020) Vol. 37, Iss. 4
Closed Access | Times Cited: 7
Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions
Andrea Passantino, Caterina Rizzo, Domenico Scrutinio, et al.
Heart Failure Reviews (2021) Vol. 28, Iss. 3, pp. 683-695
Closed Access | Times Cited: 7
The multifactorial burden of Type 2 Diabetes mellitus: a study from clinical settings of University Hospital, Karachi, Pakistan
Sidra Zaheer, Tehseen Fatima, Akhtar Ali Baloch, et al.
INTERNATIONAL JOURNAL OF ENDORSING HEALTH SCIENCE RESEARCH (IJEHSR) (2020) Vol. 8, Iss. 4, pp. 275-287
Open Access | Times Cited: 6
Sodium Intake and Proteinuria/Albuminuria in the Population—Observational, Cross-Sectional Study
Massimo Círillo, Pierpaolo Cavallo, Enrico Zulli, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1255-1255
Open Access | Times Cited: 6
A drug utilisation pattern in non-dialysis patients of diabetic nephropathy in a government-run tertiary care hospital in South-Asia
Rajmohan Seetharaman, Manjari Advani, Smita Mali, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2023) Vol. 34, Iss. 3, pp. 371-381
Closed Access | Times Cited: 2
A decade anti-diabetic potential of murraya koenigii (curry leaf): A narrative review
Arefeh Tabashiri, Mohammad Sadegh Qadirifard, Ali Ghaderi, et al.
African journal of diabetes medicine/˜The œAfrican journal of diabetes medicine (2022) Vol. 30, Iss. 3
Open Access | Times Cited: 4
Drug–drug interactions involving combinations of antipsychotic agents with antidiabetic, lipid-lowering, and weight loss drugs
A Buzea, Peter Manu, Lorena Dima, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 11, pp. 729-744
Closed Access | Times Cited: 4
Saxagliptin and vildagliptin lowered albuminuria in patients with diabetes and hypertension independent on glycaemic control
Marwa Mohsen, Ahmed A. Elberry, Alaa Mohamed Rabea, et al.
International Journal of Clinical Practice (2020) Vol. 75, Iss. 3
Open Access | Times Cited: 5
Glucagon-like peptide-1 Receptor Agonists and the Cardiorenal Axis in Type 2 Diabetes: A Focus On Dulaglutide
Richard J. MacIsaac
Future Cardiology (2021) Vol. 17, Iss. 3, pp. 459-473
Open Access | Times Cited: 5
Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy
Laure Monteillet, Philippe Labrune, Michel Hochuli, et al.
Human Molecular Genetics (2021) Vol. 31, Iss. 6, pp. 914-928
Open Access | Times Cited: 5
Characterizing Prescribing Patterns of Diabetes Medications at an Adult Medicine Clinic: A Focus on Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors
Ashley N. Shtoyko, Meaghan B. Murphy, Jenna L. Harris, et al.
Diabetes Spectrum (2024) Vol. 37, Iss. 2, pp. 180-185
Open Access
Postnatal care of women with diabetes: a clinical update
Sheena McChlery, Sadie Geraghty
British Journal of Midwifery (2024) Vol. 32, Iss. 9, pp. 492-497
Closed Access
Glucagon-like Peptide-1 Receptor Agonists: Limitless Potential
T. Yu. Demidova, A.A. Kozhevnikov
Doctor Ru (2020) Vol. 19, Iss. 2, pp. 6-12
Open Access | Times Cited: 3
Is Concomitant Therapy with Acetaminophen and Low-dose Aspirin a Risk Factor for CKD Progression? A 6-Year Cohort Study
Satoru Mitsuboshi, Hitoshi Yamada, Shuji Yamazaki, et al.
YAKUGAKU ZASSHI (2020) Vol. 140, Iss. 7, pp. 943-947
Open Access | Times Cited: 3
Hormonal imbalance in patients with chronic renal failure in the pre-dialysis and dialysis periods (part1)
I.P. Katerenchuk, S.T. Rustamyan, Viktoriia V. Talash, et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2023) Vol. 19, Iss. 1, pp. 65-71
Open Access | Times Cited: 1
Diabetes and cardiovascular disease in older adults
Anika Bilal, Richard E. Pratley
Annals of the New York Academy of Sciences (2024)
Closed Access
Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease
Hiroaki Yagyu, Hitoshi Shimano
Journal of Diabetes Investigation (2022) Vol. 13, Iss. 9, pp. 1472-1488
Open Access | Times Cited: 2
Exercise-induced albuminuria increases over time in individuals with impaired glucose metabolism
Rafael Y. Brzezinski, Limor Friedensohn, Itzhak Shapira, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 2

Scroll to top